Emergency glucagon kits are a critical line of defense against severe hypoglycemia in people with diabetes who take insulin or certain oral medications. When blood sugar drops to dangerously low levels and the individual cannot swallow, becomes unconscious, or has a seizure, glucagon can rapidly raise blood glucose. Despite their life-saving potential, many patients, caregivers, and even some healthcare providers lack confidence in when and how to use these kits. This expanded guide provides a comprehensive, evidence-based overview of emergency glucagon kits, covering their types, proper administration techniques, storage requirements, and essential safety considerations. Understanding these details can mean the difference between a manageable emergency and a tragic outcome.

Understanding Emergency Glucagon Kits

What Is Glucagon and How Does It Work?

Glucagon is a naturally occurring peptide hormone produced by the alpha cells of the pancreas. Its primary role is to counterbalance insulin by stimulating the liver to convert stored glycogen into glucose and release it into the bloodstream. In a person with diabetes, this counter-regulatory mechanism can become impaired, especially during prolonged hypoglycemia or when taking certain glucose-lowering agents. An injectable or nasally administered dose of exogenous glucagon bypasses the body's failed response and rapidly elevates blood glucose levels, usually within 5 to 15 minutes. This makes it the standard of care for severe hypoglycemic events when oral intake of carbohydrates is impossible.

Types of Emergency Glucagon Kits

Glucagon delivery has evolved significantly in recent years. Understanding the differences between available products is essential for choosing the right kit and using it correctly.

  • Traditional Rediject or GlucaGen® HypoKit®: These require reconstitution of a powder with a diluent in a syringe immediately before injection. The kit contains a vial of glucagon powder, a syringe filled with sterile water, and instructions. The user must mix the solution by rolling the vial, withdraw the reconstituted liquid, and inject it intramuscularly or subcutaneously.
  • Glucagon Auto-Injectors (e.g., Gvoke HypoPen® or Zegalogue®): These pre-filled, single-use devices contain liquid glucagon and require no mixing. The user simply removes the cap and presses the injector firmly against the outer thigh, delivering the dose automatically. These are easier and faster to use, reducing the chance of errors during a high-stress situation.
  • Nasal Glucagon (e.g., Baqsimi®): A needle-free device that delivers glucagon as a dry powder into the nostril. It is absorbed through the nasal mucosa and reaches the bloodstream without needing injection. Nasal glucagon is particularly useful for caregivers who are uncomfortable with needles or when the patient is lying on their side. No inhalation is required; the device works simply by depressing a plunger.

Each type has advantages. Nasal glucagon eliminates the risk of needle-stick injury and requires minimal training. Auto-injectors reduce preparation steps and are less intimidating for inexperienced users. Traditional kits are often more affordable and come in multi-dose vials for institutional use but demand careful mixing and injection technique.

Identifying Severe Hypoglycemia

Signs and Symptoms

Severe hypoglycemia is defined by the American Diabetes Association as a low blood glucose level (usually <54 mg/dL) accompanied by altered mental or physical status that requires the assistance of another person. Symptoms can escalate rapidly:

  • Confusion, disorientation, or inability to concentrate
  • Slurred speech or difficulty answering questions
  • Unsteadiness, weakness, or clumsiness
  • Loss of consciousness or unresponsiveness
  • Seizures or convulsions
  • Hypothermia (low body temperature) due to the metabolic crisis

Not every person with diabetes experiences the same early warning signs. Individuals who have had diabetes for many years may develop hypoglycemia unawareness, where typical adrenergic symptoms like shakiness, sweating, and palpitations are blunted. In these cases, severe hypoglycemia can occur without clear preceding symptoms. Caregivers should err on the side of caution and use glucagon if the person is unconscious or unable to swallow.

When to Use Glucagon vs. Oral Glucose

The critical decision point is whether the person is conscious and able to swallow safely. If the individual can follow commands and has intact swallowing reflexes, oral glucose (such as glucose tablets, juice, or a sugary drink) is the preferred first-line treatment. If they are confused but still able to swallow, caregivers may try to give oral carbohydrates, but only if the person can sit up and cooperate. Never attempt to force food or liquid into the mouth of an unconscious or semiconscious person—this can cause choking or aspiration pneumonia. If there is any doubt about the person's ability to swallow safely, administer glucagon immediately.

Step-by-Step Administration Guide

Using the Traditional Injectable Kit

Before an emergency arises, everyone who may need to administer glucagon should watch a demonstration and practice with a trainer or verify steps on the manufacturer's website. The general process for a traditional kit (e.g., GlucaGen HypoKit) is as follows:

  1. Open the kit and remove the vial of glucagon powder and the syringe filled with sterile water.
  2. Remove the protective cap from the vial and the needle cover from the syringe.
  3. Insert the needle through the rubber stopper of the vial and inject all the water into the vial.
  4. Gently roll the vial between your palms to mix the powder and water. Do not shake vigorously, as frothing can affect the dose.
  5. Inspect the solution. It should be clear and colorless. Do not use if it contains particles or appears discolored.
  6. Withdraw the full contents of the vial back into the syringe.
  7. Clean the injection site (upper outer thigh, deltoid, or buttock) with an alcohol wipe if available.
  8. Insert the needle at a 90-degree angle into the chosen muscle and inject the medication steadily. For children, use the outer thigh.
  9. Remove the needle and briefly apply pressure with a dry gauze or tissue. Do not rub.
  10. Turn the person onto their side (recovery position) to protect the airway in case of vomiting.
  11. Immediately call emergency medical services (911 in the U.S.) or arrange transport to a hospital.

Write down the time of administration and the dose given. This information is crucial for paramedics and emergency department staff.

Using a Glucagon Auto-Injector

Devices like Gvoke HypoPen simplify the process:

  1. Remove the auto-injector from its carrying case and pull off the safety cap.
  2. Place the black end of the injector firmly against the outer thigh. It can be given through clothing if thin.
  3. Press and hold the injector firmly for 5–10 seconds (depending on the specific model). You will hear a click when the injection begins.
  4. Remove the injector and massage the injection site for a few seconds if needed.
  5. Turn the person on their side and call 911.

Using Nasal Glucagon

Baqsimi nasal powder is administered with minimal steps:

  1. Remove the device from its blister package. the device has a green top and a red plunger.
  2. Gently insert the tip of the device into one nostril until your finger touches the nose.
  3. Press the red plunger firmly to deliver the entire dose.
  4. Remove the device from the nostril. There is no need to tilt the head or have the person inhale.
  5. Turn the person on their side and call 911.
  6. Note: If the person does not wake up within 15 minutes, a second dose may be given (if available) while waiting for emergency services.

Post-Administration Care and Emergency Follow-Up

After administering glucagon, the person may regain consciousness within 5–15 minutes. However, glucagon's effect is relatively short-lived (about 30–60 minutes), and the danger of hypoglycemia may return. Do not leave the person unattended. Once they are alert and able to swallow, give a fast-acting source of oral carbohydrate (e.g., juice, glucose tablets, or a regular soda) to prevent a second drop. Continue to monitor for signs of hypoglycemia. If the person remains unconscious after 15 minutes, a second dose (if available) should be administered, but only if emergency medical services have not yet arrived. All glucagon events require medical evaluation—even if the person appears fully recovered—because there could be underlying causes (such as an overdose of insulin or sulfonylurea) that need management, and because glucagon can trigger vomiting, leading to hydration issues.

Storage, Expiration, and Carrying Tips

Glucagon is a fragile hormone. Improper storage can render the kit ineffective when it is needed most.

  • Store all glucagon products at room temperature (68–77°F or 20–25°C), away from heat, moisture, and direct light.
  • Do not refrigerate or freeze—extreme temperatures can degrade the powder or liquid.
  • Check the expiration date on the kit every month. Replace expired kits immediately; some manufacturers offer expiration reminder programs.
  • For traditional kits, the reconstituted solution must be used within one hour of mixing and cannot be saved for later use.
  • Carry a glucagon kit wherever you go—work, school, travel, sports events. If the person with diabetes is an insulin user, a glucagon kit should accompany them like a spare insulin pen.
  • Consider keeping a second kit in a secondary location (e.g., vehicle glove box, gym bag, or beside the bed).
  • In hot climates, avoid leaving the kit in a parked car. In cold climates, keep it close to the body to prevent freezing.

Training Caregivers and Family Members

Anyone likely to be present during a severe hypoglycemic episode—spouse, parent, roommate, teacher, coach, coworker—should receive hands-on training on how to recognize severe hypoglycemia and use the specific glucagon product prescribed. The training should include:

  • Review of symptoms and when to act
  • Step-by-step practice with an expired or dummy device (many manufacturers provide trainers)
  • Instructions on placing the person in the recovery position
  • How to call emergency services and convey the situation
  • Where the glucagon kit is stored

The American Diabetes Association recommends that all people with type 1 diabetes and those with type 2 diabetes at risk for hypoglycemia (e.g., on intensive insulin therapy) have a glucagon kit available at home, at school, and at work, and that caregivers receive periodic refresher training. For children with diabetes, school nurses and teachers should be trained annually.

Special Populations

Children and Adolescents

Pediatric glucagon dosing depends on body weight. Most kits come in a 1 mg standard adult dose and a 0.5 mg pediatric dose (for infants and children under 25 kg or 55 lbs). Nasal glucagon (Baqsimi) is approved for ages four and older at the same 3 mg dose as for adults. For younger children, injectable glucagon is preferred. Caregivers should verify the correct dose with a healthcare provider and keep a pediatric kit on hand. Because children are more prone to vomiting after glucagon, maintaining airway protection and rechecking blood glucose soon after consciousness returns is extra important.

Older Adults

Elderly individuals often have comorbidities such as cardiovascular disease, renal impairment, or polypharmacy. Glucagon can cause a transient increase in heart rate and blood pressure due to its positive inotropic effects. While generally safe, older adults may be at higher risk for nausea and vomiting. They also may be less able to recognize or communicate symptoms of severe hypoglycemia. Caregivers should monitor post-glucagon recovery closely and coordinate with emergency services to address any potential drug interactions or underlying conditions.

Pregnancy

Severe hypoglycemia in a pregnant person with diabetes can harm the fetus. Glucagon is considered low risk during pregnancy because it mimics a naturally occurring hormone, and the benefit of preventing prolonged hypoglycemia outweighs theoretical concerns. However, maternal vomiting can lead to dehydration and electrolyte imbalances, so supportive care and early hospital evaluation are essential.

Side Effects and Precautions

The most common side effect of glucagon administration is nausea and vomiting, which occurs in about 30–40% of recipients. This can happen even if the person is unconscious, so proper airway management (placing them on their side) is critical. Other possible effects include:

  • Weakness or headache
  • Injection site pain or swelling (for injectable forms)
  • Nasal discomfort or runny nose (with nasal glucagon)
  • Rapid heart rate or palpitations (transient)
  • Severe allergic reactions (very rare, but possible)

Glucagon is contraindicated in people with a known hypersensitivity to glucagon (uncommon) or in patients with pheochromocytoma or insulinoma (because it can cause dangerous catecholamine release or rebound hypoglycemia after glucose elevation). It should be used with caution in patients with cardiac disease due to potential hemodynamic changes.

In many jurisdictions, glucagon is a prescription-only medication. Patients with diabetes should discuss obtaining a glucagon kit with their healthcare provider, even if they have never had a severe hypoglycemic event. Insurance coverage varies; some plans cover all three types, while others require prior authorization for newer products like auto-injectors or nasal glucagon. Patient assistance programs offered by manufacturers can help reduce out-of-pocket costs for those without adequate insurance. Schools and workplaces must comply with disability accommodations—for example, the Americans with Disabilities Act requires that glucagon administration training be provided to designated personnel.

It is also important to note that glucagon can be lawfully administered by non-medical professionals (e.g., family members, teachers, coworkers) during an emergency. Good Samaritan laws generally protect those who act in good faith to help. Still, many organizations encourage formal training and written emergency action plans.

Conclusion

Emergency glucagon kits are not just a precaution—they are an essential piece of diabetes management for anyone at risk of severe hypoglycemia. Knowing which type of kit you have, how to administer it correctly, and when to use it can save lives. Equally important is the aftercare: calling 911, placing the person in the recovery position, and monitoring for a second drop in blood glucose. By staying prepared, you turn a potential tragedy into a manageable emergency. For more detailed guidance, consult the resources provided by the American Diabetes Association, the FDA glucagon product information, and JDRF. Share this article with your support network and practice with a demo device so that when the moment comes, you’re ready to act.